Cellcloud

About Cellcloud

CellCloud, a pioneering company in the medical technology sector, specializes in early cancer detection through advanced micro CC scans. Founded by former university professors and medical experts, the company focuses on identifying malignant tumors at an early stage, thereby increasing the chances of successful treatment. CellCloud primarily serves healthcare providers, research institutions, and medical facilities in Japan, where cancer remains a leading cause of mortality. The company operates in the healthcare diagnostics market, leveraging cutting-edge technology to offer precise and reliable cancer risk assessments. Its business model revolves around providing cancer risk testing services, generating revenue through service fees and partnerships with medical institutions. By addressing the critical need for early cancer detection, CellCloud aims to reduce the mortality rate associated with late-stage cancer diagnoses.